Chewy Inc

Aktienanalyse zu Chewy Inc (CHWY)

$23.260

+0.470 (+2.02%)Zum Schluss

Loading chart…
High
23.735
Open
22.900
VWAP
23.27
Vol
5.01M
Mkt Cap
12.66B
Low
22.815
Amount
116.59M
EV/EBITDA, TTM
13.56

Chewy, Inc. provides pet food and treats, pet supplies and pet medications, other pet-health products, and pet services. The Company offers websites and mobile applications which allow pet parents to manage pets’ health, wellness, and merchandise needs. It offers customers approximately 190,000 products and service offerings. It operates fulfillment centers located in the United States and Canada. It offers a range of educational media, such as blogs, videos, and tutorials on the website, Chewy.com/education and pet health focused content on the website, PetMD.com. It operates eight veterinary clinics under the brand name Chewy Vet Care, offering pet health services including routine appointments, urgent care and surgery. Its trademarks include American Journey, Blue Box Event, CarePlus, Chewy, Chewy.com, Chewy Vet Care, Dr. Lyon’s, Frisco, Get Real, Goody Box, Onguard, PetMD, PracticeHub, Tiny Tiger, True Acre Farms, Tylee’s, Vibeful, and The Zoo.

www.chewy.com

AI analysis of Chewy Inc (CHWY)

hold

Chewy Inc is currently trading at $23.26, which is 46% below its 52-week high, indicating potential for recovery. However, the RSI is at 47.696, suggesting the stock is neither overbought nor oversold, and the forward P/E ratio is 15.625, which is relatively attractive compared to its historical valuations. The main risk is the insider selling, which has increased by 2640.37%, indicating potential lack of confidence from insiders.

Bewertungskennzahlen

The current forward P/E ratio for Chewy Inc (CHWY) is 15.63, compared to its 5-year average forward P/E of 76.54.

Forward P/E

Fair
5Y Average P/E
76.54
Current P/E
15.63
Überbewertet
1043.48
Unterbewertet
-890.40

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
53.82
Current EV/EBITDA
13.56
Überbewertet
121.19
Unterbewertet
-13.55

Forward P/S

Undervalued
5Y Average P/S
1.25
Current P/S
0.65
Überbewertet
1.83
Unterbewertet
0.66

Alphio AI Price Scenarios for CHWY

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CHWY

$56.49

Szenariopreis

B

Base

Base · 50%CHWY

$48.10

Szenariopreis

B

Bear

Bear · 25%CHWY

$41.87

Szenariopreis

Whales holding CHWY

I

Invenomic Capital Management LP

+ HoldingCHWY

+14.54%

3M Return

B

BC Partners PE L.P.

+ HoldingCHWY

+4.40%

3M Return

P

PetSmart LLC

+ HoldingCHWY

+4.40%

3M Return

T

The First National Bank Wealth Management Group

+ HoldingCHWY

+1.59%

3M Return

S

Senvest Management, LLC

+ HoldingCHWY

+0.03%

3M Return

CHWY FAQ — answered by Alphio AI

Chewy, Inc. provides pet food and treats, pet supplies and pet medications, other pet-health products, and pet services. The Company offers websites and mobile applications which allow pet parents to manage pets’ health, wellness, and merchandise needs. It offers customers approximately 190,000 products and service offerings. It operates fulfillment centers located in the United States and Canada. It offers a range of educational media, such as blogs, videos, and tutorials on the website, Chewy.com/education and pet health focused content on the website, PetMD.com. It operates eight veterinary clinics under the brand name Chewy Vet Care, offering pet health services including routine appointments, urgent care and surgery. Its trademarks include American Journey, Blue Box Event, CarePlus, Chewy, Chewy.com, Chewy Vet Care, Dr. Lyon’s, Frisco, Get Real, Goody Box, Onguard, PetMD, PracticeHub, Tiny Tiger, True Acre Farms, Tylee’s, Vibeful, and The Zoo. It operates in the Consumer Cyclicals sector (RETAIL-CATALOG & MAIL-ORDER HOUSES industry).

Chewy Inc is currently trading at $23.26, which is 46% below its 52-week high, indicating potential for recovery. However, the RSI is at 47.696, suggesting the stock is neither overbought nor oversold, and the forward P/E ratio is 15.625, which is relatively attractive compared to its historical valuations. The main risk is the insider selling, which has increased by 2640.37%, indicating potential lack of confidence from insiders.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten